SCHEMBL475622

SCHEMBL475622

CC1(C)CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28507752 0.97
SCHEMBL27686974 0.97
Hydrochloric Acid SCHEMBL1159516 0.97
SCHEMBL989854 0.90
Iodide SCHEMBL23270643 0.88
SCHEMBL22641427 0.88 ALPL (0.33)
Bromide SCHEMBL11117953 0.88
Water SCHEMBL21518343 0.88
SCHEMBL22641431 0.88 ALPL (0.33)
SCHEMBL28513414 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 742 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404283-B2 c-MYC mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-09-02 US claimed
CN-120035580-A Novel piperazinyl sulfonamides and their use as neuroprotective and/or neurorestorative agents 基因密码公司 2025-05-23 CN claimed
EP-4547672-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2025-05-07 EP claimed
US-20250129100-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2025-04-24 US claimed
WO-2024079351-A1 NOVEL PIPERAZINE-BASED SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS GENECODE (EE) 2024-04-18 WO claimed
WO-2024010762-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2024-01-11 WO claimed
EP-4267585-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS Actelion Pharmaceuticals Ltd (CH) 2023-11-01 EP claimed
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 WO claimed
EP-3814323-A1 HYDROGENATION PROCESS Johnson Matthey Public Limited Company (GB) 2021-05-05 EP claimed
WO-2017186881-A1 METHODS FOR MAKING POLY(ARYL ETHER SULFONE) POLYMERS AND POLYMER COMPOSITIONS AND ARTICLES INCLUDING THE SAME SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2017-11-02 WO claimed
CN-1237159-A Enantiomerically pure basic aryl-cycloalkyl-hydroxycarboxylic esters, process for their preparation and their use in medicaments CHRISTIAN R NOE (DE) 1999-12-01 CN claimed
WO-1999042424-A1 METHOD FOR PREPARING AROMATIC KETONE COMPOUNDS RHODIA CHIMIE (FR) 1999-08-26 WO claimed
WO-1999018064-A1 METHOD FOR FUNCTIONALIZING A PHENOLIC COMPOUND BEARING AN ELECTRON-DONOR GROUP RHODIA CHIMIE (FR) 1999-04-15 WO claimed
WO-1998047848-A1 METHOD FOR PREPARING AROMATIC ALDEHYDES RHODIA CHIMIE (FR) 1998-10-29 WO claimed
EP-0687258-B1 SUBSTITUTED IMINOACETONITRILES WITH MYOCARDIAL PROTECTIVE EFFECT HOECHST AG (DE) 1998-07-22 EP claimed
EP-0687258-A1 SUBSTITUTED IMINOACETONITRILES WITH MYOCARDIAL PROTECTIVE EFFECT HOECHST AKTIENGESELLSCHAFT (DE) 1995-12-20 EP claimed
WO-1994020482-A1 SUBSTITUTED IMINOACETONITRILES WITH MYOCARDIAL PROTECTIVE EFFECT HOECHST AKTIENGESELLSCHAFT (DE) 1994-09-15 WO claimed
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP claimed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP claimed
EP-0094283-B1 SUSTAINED-RELEASE THEOPHYLLIN DRUG FORMULATION LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1985-11-21 EP claimed